Tangeretin inhibits extracellular-signal-regulated kinase (ERK) phosphorylation

FEBS Lett. 2005 Mar 14;579(7):1665-9. doi: 10.1016/j.febslet.2004.10.114.

Abstract

Tangeretin is a methoxyflavone from citrus fruits, which inhibits growth of human mammary cancer cells and cytolysis by natural killer cells. Attempting to unravel the flavonoid's action mechanism, we found that it inhibited extracellular-signal-regulated kinases 1/2 (ERK1/2) phosphorylation in a dose- and time-dependent way. In human T47D mammary cancer cells this inhibition was optimally observed after priming with estradiol. The spectrum of the intracellular signalling kinase inhibition was narrow and comparison of structural congeners showed that inhibition of ERK phosphorylation was not unique for tangeretin. Our data add tangeretin to the list of small kinase inhibitors with a restricted intracellular inhibition profile.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Breast Neoplasms / enzymology*
  • Cell Line, Tumor
  • Estradiol / pharmacology
  • Extracellular Signal-Regulated MAP Kinases / antagonists & inhibitors*
  • Female
  • Flavones / pharmacology*
  • Humans
  • Mitogen-Activated Protein Kinase 1 / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase 3 / antagonists & inhibitors
  • Molecular Structure
  • Phosphorylation / drug effects
  • Protein Kinase Inhibitors / pharmacology*
  • Signal Transduction / drug effects

Substances

  • Antineoplastic Agents, Phytogenic
  • Flavones
  • Protein Kinase Inhibitors
  • Estradiol
  • Extracellular Signal-Regulated MAP Kinases
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • tangeretin